Glucagon-like peptide-1 (GLP-1) agonist are a family of medications that help manage blood sugar in patients with type 2 ...
A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...
Business Insider on MSN1h
How RFK Jr.'s war on obesity in the age of Ozempic could shake up the booming weight-loss industryKennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...
First for Women on MSN21h
NK2R: A Side-Effect-Free Ozempic Alternative for Weight LossOzempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, ...
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
NBC Los Angeles on MSN18h
FDA weighs in on diet drug shortage, creating more confusion about compoundingAs millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study ...
verywellhealth on MSN2h
21 Reasons You’re Not Losing Weight—and How to Address ThemIf you are currently focusing on weight loss, you may have noticed that losing weight initially seemed easier. It is common ...
Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback